🔗 Permalink

Inventor profile of:

Eileen JACKSON

City:

Kaiseraugst

Country:

Switzerland

Published Applications:

Last publication date:

2025-05-22

Top Assignees for applications by Eileen JACKSON

The entities that hold a legal rights for patent applications filed by inventor JACKSON Eileen:

DSM IP ASSETS B.V. 10 Heerlen, Netherlands

Recent patent applications by JACKSON Eileen

Eileen JACKSON from Kaiseraugst, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-22

US20250161232A1

Human necessities

RETINOL FORMULATION (VI)

#2 | 2025-05-15

US20250152493A1

Human necessities

RETINOL FORMULATION (V)

#3 | 2025-05-01

US20250134834A1

Human necessities

RETINOL FORMULATION (IV)

#4 | 2025-02-06

US20250040538A1

Human necessities

NOVEL COMPOSITIONS COMPRISING TRANS RETINOL

#5 | 2021-09-09

US20210277058A1

Chemistry; metallurgy

Melanocortin-1-receptor agonists

#6 | 2020-10-01

US20200308222A1

Chemistry; metallurgy

ANTIMICROBIAL TETRAPEPTIDES

#7 | 2020-09-17

US20200290960A1

Chemistry; metallurgy

Biaromatic compounds, which are vitamin D analogs

#8 | 2019-09-26

US20190290563A1

Human necessities

Biaromatic vitamin D analogs

#9 | 2019-08-29

US20190263858A1

Chemistry; metallurgy

Compounds

#10 | 2019-01-03

US20190002378A1

Chemistry; metallurgy

Biaromatic vitamin D analogs

#11 | 2018-12-20

US20180362428A1

Chemistry; metallurgy

Compounds

#12 | 2018-12-13

US20180353563A1

Human necessities

Method for the treatment of skin disorders using dipeptide diaminobutyroyl benzylamide diacetate

#13 | 2018-12-06

US20180344604A1

Human necessities

(R)-N-(adamantyl-2-yl)pyrrolidine-2-carboxamide derivatives for cosmetic use

#14 | 2018-11-08

US20180319829A1

Chemistry; metallurgy

Phosphinic peptide derivatives for use as MMP-12 inhibitors

#15 | 2018-07-26

US20180208576A1

Chemistry; metallurgy

Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

InventorID:

2251296 ⎘